Progress..again Anyone notice that ever since the doji

New Post Public Reply Private Reply Replies (1) Message Board
joey68
Progress..again

Anyone notice that ever since the doji on February 18, 2016, the 50MA and 200MA have consistently inched their way closer and closer?

Despite the run up to .0092 and then back down to .003, these two lines have steadily worked their way closer.

My post from yesterday showed they were only separated by .0047

But now, just one day later (as of this post), they are separated by only .0046 !

Slowly but surely SCIE continues to grow. Sure, it may not be as fast as some might like, but I'm loving this.

The great thing about this chart is the timing. We have the 10Q coming out soon. It's possible we will have a Golden Cross around the same time as the 10Q. Now THAT would be interesting!

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Safety and Wellbeing as Key Business Strategy Focus

Updated Category News Views 2

Revolutionizing Safety in the Workplace Cracking the typical mindset of treating employee safety as a checkbox item, Debra Wein, CEO and Founder of Wellness Workdays, is set to shake up the NSC Safety Congress & Expo. Her upcoming session, titled "Transforming Safety and Wellbeing into a Competitive Business Advantage," isn't just a run-of-the-mill talk. It's a call to...

Continue Reading
Connected Retail Security: Rising Risks and Fragmented Roles

Updated Category News Views 4

Cyber Threats in the Connected Retail Landscape The retail world isn't what it used to be. Walk into a store today, and you're greeted not just by products but a web of interconnected systems screaming for attention. Sure, you've got your old-school POS systems humming along, but they're just one brittle cog in a rattling machine of IoT devices, cloud platforms, and...

Continue Reading
CAPR Faces Lawsuit and FDA Delay: Investor Alert

Updated Category News Views 1

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Continue Reading
Courtesy Auto Group Expands with Tucson Dealerships Buy

Updated Category News Views 6

Moving Pieces in the Automotive Puzzle Here's one for the books, folks. Automotive dealership chessboard gets another shuffle. Scott Gruwell, the big wheel behind Courtesy Automotive Group, has snatched up Watson Chevrolet and Infiniti of Tucson. Just one more notch in someone's power belt—operations now rolling under new banners as Courtesy Chevrolet and Courtesy...

Continue Reading
Aurzen Leverages Basquiat for Art-Infused Projection Line

Updated Category News Views 2

A Fresh Perspective on Portable Projection If anyone had told me a tech brand would buddy up with the world of fine art to launch a new gadget line, I'd have raised an eyebrow. But here we are, shrugging away the standard and looking at what's cooking over at Aurzen. The company's new initiative, 'Unfold the Art,' marries the magnetism of Jean-Michel Basquiat's artwork...

Continue Reading
JIMMY's Nespure N9: Innovating Coffee and Clean Water

Updated Category News Views 2

Unpacking JIMMY's Latest Innovation at IFA Every now and then, something comes along that makes you think, "Why didn't I think of that?" Well, JIMMY just hit that nail square on the head with its latest concoction—the Nespure N9. Debuting at the IFA 2026 in Berlin, this little gizmo combines water purification with coffee brewing, all from a modestly-sized countertop...

Continue Reading
Ed Markey's Political Future on Shaky Ground in MA

Updated Category News Views 2

Massachusetts Voters Voice Desire for Change Ever seen an old engine stutter and cough before finally quitting? That's what Ed Markey's political career is starting to feel like. A fresh poll has surfaced, casting doubt over his steady grip on his longstanding Senate seat in Massachusetts. People are yearning for fresh faces and new ideas like never before. It's as if the...

Continue Reading
Ribbonwire Ranch Hits Sheetz Milestone with Campaign

Updated Category News Views 5

Where Beef Snacks Meet Road Tales Just a year ago, Ribbonwire Ranch, a small Texas-based beef snack producer, made its debut at Sheetz stores. Now, they're not just another brand on the shelf; they're weaving tales from the road with their latest venture, the "Dashboard Diaries" campaign. If you're wondering how a beef snack producer finds itself in an eight-week...

Continue Reading
October 15 Marks Prologis Q3 2026 Results Call

Updated Category News Views 2

Prologis Steps Up to the Plate This October If you’ve got a finger in any logistic pies, make sure it's wrapped around the latest from Prologis come October 15. The logistics behemoth is rolling out the red carpet for its third quarter results, with all eyes on what their senior management will spill. Frankly, you don’t just show up to these things to sip coffee and...

Continue Reading
Baidu Joins Shanghai-HK Connect, Expanding Reach

Updated Category News Views 0

Big News from Baidu: Connect Program Inclusion Bet you didn't see this one coming. Baidu, the titan of AI in China, just rolled out some significant buzz. Starting September 7th, their Class A ordinary shares will join the Shanghai-Hong Kong Stock Connect program, shaking things up on the Shanghai Stock Exchange. This move is set to give investors from the Chinese...

Continue Reading

Top 5 Most Recently Viewed Articles

Carolwood Estates Shares Impressive 2025 Midyear Market Insights

Updated Category News Views 94

Carolwood Estates Provides Key Insights in Its 2025 Midyear Report Carolwood Estates recently announced the release of its 2025 Midyear Report. This comprehensive document highlights the company's significant role in the luxury real estate market, showcasing their performance in brokered sales and market share. Dominance in Luxury Sales This year, Carolwood Estates stood...

Continue Reading
Sysco's Q1 2026 Highlights: Growth in Earnings and Sales

Updated Category News Views 236

Sysco Corporation Reports Strong First Quarter 2026 Results Sysco Corporation (NYSE:SYY), a prominent leader in selling and distributing food, announced robust financial results for the first quarter of its fiscal year 2026, covering the 13-week period ending September 27, 2025. With noteworthy growth and solid market performance, Sysco continues to reinforce its leading...

Continue Reading
Homology Medicines Faces Setbacks as QTTB Stock Plummets

Updated Category News Views 96

Market Challenges and QTTB Stock Decline Homology Medicines Inc. (NASDAQ: QTTB) has recently faced a tumultuous period, with its stock plunging to a troubling 52-week low of $3.34. This decline illustrates the broader economic pressures impacting the company and its stakeholders. The current landscape shows that despite some positive financial indicators, including a...

Continue Reading
GSK's Shingrix Syringe Design Aims to Transform Shingles Care

Updated Category News Views 273

GSK Seeks EMA Approval for Innovative Shingrix Syringe In an important development for public health, GlaxoSmithKline PLC (NYSE: GSK) is under review by the European Medicines Agency (EMA) for its new prefilled syringe version of Shingrix, which serves as a vaccine to prevent the painful condition known as shingles. This new design aims to simplify how healthcare...

Continue Reading
AC Reports Positive Preliminary Book Value for Third Quarter

Updated Category News Views 94

Preliminary Book Value Announcement from AC Associated Capital Group, Inc. (NYSE: AC), based in Greenwich, Connecticut, has recently announced exciting news regarding its financial performance. The company revealed a preliminary estimate for its third quarter book value ranging between $41.85 and $42.05 per share. This latest estimation excludes a special dividend of $2...

Continue Reading